Authors: BOROVITSKAYA AE DARPA P

Citation: Ae. Borovitskaya et P. Darpa, REPLICATION-DEPENDENT AND REPLICATION-INDEPENDENT CAMPTOTHECIN CYTOTOXICITY OF 7 HUMAN COLON-TUMOR CELL-LINES, Oncology research, 10(5), 1998, pp. 271-276

Authors: LIU LF DESAI SD SIM SP PILCH DS LI TK LAVOIE EJ SANDERS M DARPA P WANG H WU JX LIU A YU C

Citation: Lf. Liu et al., ORIGIN OF THE ANTICANCER ACTIVITY OF TOPOISOMERASE INHIBITORS, Annals of oncology, 9, 1998, pp. 40-40

Authors: BARROWS LR HOLDEN JA ANDERSON M DARPA P

Citation: Lr. Barrows et al., THE CHO XRCC1 MUTANT, EM9, DEFICIENT IN DNA-LIGASE-III ACTIVITY, EXHIBITS HYPERSENSITIVITY TO CAMPTOTHECIN INDEPENDENT OF DNA-REPLICATION, Mutation research. DNA repair, 408(2), 1998, pp. 103-110

Authors: DESAI SD LIU LF VAZQUEZABAD D DARPA P

Citation: Sd. Desai et al., UBIQUITIN-DEPENDENT DESTRUCTION OF TOPOISOMERASE-I IS STIMULATED BY THE ANTITUMOR DRUG CAMPTOTHECIN, The Journal of biological chemistry, 272(39), 1997, pp. 24159-24164

Authors: DARPA P LIU LF

Citation: P. Darpa et Lf. Liu, CELL CYCLE-SPECIFIC AND TRANSCRIPTION-RELATED PHOSPHORYLATION OF MAMMALIAN TOPOISOMERASE-I, Experimental cell research, 217(1), 1995, pp. 125-131

Authors: TSAO YP DARPA P LIU LF

Citation: Yp. Tsao et al., THE INVOLVEMENT OF ACTIVE DNA-SYNTHESIS IN CAMPTOTHECIN-INDUCED G2 ARREST - ALTERED REGULATION OF P34CDC2 CYCLIN-B, Cancer research, 52(7), 1992, pp. 1823-1829